{"id":21758,"date":"2024-09-13T07:32:27","date_gmt":"2024-09-13T11:32:27","guid":{"rendered":"https:\/\/massivebio.com\/?p=21758"},"modified":"2025-09-24T10:37:38","modified_gmt":"2025-09-24T07:37:38","slug":"massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment","status":"publish","type":"post","link":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/","title":{"rendered":"Massive Bio and Foundation Medicine Partner to Optimize Clinical Trial Recruitment and Enrollment to Expand Access to Precision Cancer Care"},"content":{"rendered":"<section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. today announced a strategic collaboration to increase patient access to cutting edge clinical trials. This collaboration unites Massive Bio\u2019s patient matching technology and last-mile solutions with Foundation Medicine\u2019s global expertise and leadership in next generation sequencing (NGS) and network of healthcare providers.<\/p>\n<p>This partnership seeks to improve the low rate of patient enrollment in oncology clinical trials, which sees only about 8% of eligible patients participating in clinical trials<sup>1<\/sup>. As potential new therapies increasingly address rare cancers, approximately 80% of clinical studies globally fail to enroll enough patients with a biopharmaceutical company\u2019s desired timeline, according to a 2020 report published in Perspectives in Clinical Research<sup>2<\/sup>. The cornerstone of this partnership lies in integrated solutions that enhance service delivery for both Massive Bio\u2019s and Foundation Medicine\u2019s customers through shared data and AI analytics focused on patient matching.<\/p>\n<p>&#8220;The application of real-time AI and our comprehensive data significantly boosts the speed and accuracy of clinical trial matching,\u201d said <u style=\"color: #0000ff;\"><a style=\"color: #0000ff;\" href=\"https:\/\/www.linkedin.com\/in\/arturoloaizabonillla\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span style=\"color: #0000ff;\">Dr. Arturo Loaiza-Bonilla, MD MSEd<\/span>,<\/a><\/u> Co-founder and Chief Medical Officer at Massive Bio. \u201cThis capability allows us to provide individualized treatments more quickly and accurately, enhancing patient outcomes across the globe. Joining forces with Foundation Medicine is pivotal as it will allow us to develop solutions to the cancer clinical trial enrollment paradox.&#8221;<\/p>\n<p>Massive Bio is building the largest global oncology\/hematology network to transform patient recruitment at scale with more than 132,000 patients, 5,000 physicians, 40 pharma and CRO customers and 50 partners. Massive Bio\u2019s real-time, AI-driven platform, Synergy-AI, can analyze and summarize extensive medical records, including biomarker data from multiple sources, to match patients with over 16,000 clinical trials instantly. Massive Bio\u2019s predictive analytics maximizes trial enrollment potential and significantly reduces screen failures.<\/p>\n<p>Through this partnership, Massive Bio and Foundation Medicine hope to increase clinical trial enrollment with their extensive networks and capabilities across the healthcare landscape, employing advanced AI techniques and a robust digital health platform to refine clinical trial processes and enhance precision oncology.<\/p>\n<p>&#8220;Beyond providing high quality genomic profiling to support informed decision making, Foundation Medicine is committed to empowering practitioners to act on those decisions by identifying personalized treatment options including clinical trials,\u201d said Heather Jorajuria, Senior Vice President, Clinical ; Scientific Operations at Foundation Medicine. \u201cThrough this partnership with Massive Bio, we have the patient at the forefront, leveraging our combined assets and expertise to improve access to clinical trials for patients.\u201d<\/p>\n<p>1 Unger JM Vaidya R Hershman DL, et al.: Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial par<\/p>\n<p>2 Desai.2020 Apr-Jun 2020. Recruitment and retention of participants in clinical studies: Critical Issues and challenges. <span style=\"color: #0000ff;\"><u><a style=\"color: #0000ff;\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7342339\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.ncbi.nlm.nih.gov\/<\/a><\/u><\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. today announced a strategic collaboration to increase patient access to cutting edge clinical trials. This collaboration unites Massive Bio\u2019s patient matching technology and last-mile solutions with Foundation Medicine\u2019s global expertise and leadership in next generation sequencing (NGS) and network of...","protected":false},"author":11,"featured_media":22085,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-21758","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Massive Bio and Foundation Medicine Partner to Optimize Clinical Trial Recruitment and Enrollment to Expand Access to Precision Cancer Care<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Massive Bio and Foundation Medicine Partner to Optimize Clinical Trial Recruitment and Enrollment to Expand Access to Precision Cancer Care %\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-13T11:32:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-24T07:37:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2024\/09\/massive-bio-and-foundation-medicine-partner-mobile.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"576\" \/>\n\t<meta property=\"og:image:height\" content=\"432\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Massive Bio and Foundation Medicine Partner to Optimize Clinical Trial Recruitment and Enrollment to Expand Access to Precision Cancer Care","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/","og_locale":"en_US","og_type":"article","og_title":"Massive Bio and Foundation Medicine Partner to Optimize Clinical Trial Recruitment and Enrollment to Expand Access to Precision Cancer Care %","og_url":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2024-09-13T11:32:27+00:00","article_modified_time":"2025-09-24T07:37:38+00:00","og_image":[{"width":576,"height":432,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2024\/09\/massive-bio-and-foundation-medicine-partner-mobile.webp","type":"image\/webp"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"Massive Bio and Foundation Medicine Partner to Optimize Clinical Trial Recruitment and Enrollment to Expand Access to Precision Cancer Care","datePublished":"2024-09-13T11:32:27+00:00","dateModified":"2025-09-24T07:37:38+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/"},"wordCount":490,"commentCount":0,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2024\/09\/massive-bio-and-foundation-medicine-partner-mobile.webp","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/","url":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/","name":"Massive Bio and Foundation Medicine Partner to Optimize Clinical Trial Recruitment and Enrollment to Expand Access to Precision Cancer Care","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2024\/09\/massive-bio-and-foundation-medicine-partner-mobile.webp","datePublished":"2024-09-13T11:32:27+00:00","dateModified":"2025-09-24T07:37:38+00:00","breadcrumb":{"@id":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2024\/09\/massive-bio-and-foundation-medicine-partner-mobile.webp","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2024\/09\/massive-bio-and-foundation-medicine-partner-mobile.webp","width":576,"height":432,"caption":"Massive Bio and Foundation Medicine Partner to Optimize Clinical Trial Recruitment and Enrollment to Expand Access to Precision Cancer Care"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/massive-bio-and-foundation-medicine-partner-to-optimize-clinical-trial-recruitment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/massivebio.com\/resources\/news-en\/"},{"@type":"ListItem","position":3,"name":"Massive Bio and Foundation Medicine Partner to Optimize Clinical Trial Recruitment and Enrollment to Expand Access to Precision Cancer Care"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists &amp; Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/21758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=21758"}],"version-history":[{"count":1,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/21758\/revisions"}],"predecessor-version":[{"id":37768,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/21758\/revisions\/37768"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/22085"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=21758"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=21758"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=21758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}